Related Content
Search Google Scholar for:
|
|
Science 11 September 1987:
Vol. 237. no. 4820, pp. 1340 - 1343
DOI: 10.1126/science.2888191
|
|
Articles
Science, Vol 237, Issue 4820, 1340-1343
Copyright © 1987 by American Association for the Advancement of Science
A transgenic mouse model for human neurofibromatosis
SH Hinrichs,
M Nerenberg,
RK Reynolds,
G Khoury,
and
G Jay
Human T-lymphotropic virus type 1 (HTLV-1) has been associated with the neurologic disorder tropical spastic paraparesis and possibly with multiple sclerosis. The tat gene of HTLV-1 under control of its own long terminal repeat is capable of inducing tumors in transgenic mice. The morphologic and biologic properties of these tumors indicate their close resemblance to human neurofibromatosis (von Recklinghausen's disease), the most common single gene disorder to affect the nervous system. The high spontaneous incidence of this disease, together with the diverse clinical and pathologic features associated with it, suggests that environmental factors may account for some of the observed cases. Multiple tumors developed simultaneously in the transgenic tat mice at approximately 3 months of age, and the phenotype was successfully passed through three generations. The tumors arise from the nerve sheaths of peripheral nerves and are composed of perineural cells and fibroblasts. Tumor cells from these mice adapt easily to propagation in culture and continue to express the tat protein in significant amounts. When transplanted into nude mice, these cultured cells efficiently induce tumors. Evidence of HTLV-1 infection in patients with neural and other soft tissue tumors is needed in order to establish a link between infection by this human retrovirus and von Recklinghausen's disease and other nonlymphoid tumors.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- Small-Molecule Inhibitor Which Reactivates p53 in Human T-Cell Leukemia Virus Type 1-Transformed Cells.
- K.-J. Jung, A. Dasgupta, K. Huang, S.-J. Jeong, C. Pise-Masison, K. V. Gurova, and J. N. Brady (2008)
J. Virol.
82, 8537-8547
| Abstract »
| Full Text »
| PDF »
- HBZ, a new important player in the mystery of adult T-cell leukemia.
- J.-M. Mesnard, B. Barbeau, and C. Devaux (2006)
Blood
108, 3979-3982
| Abstract »
| Full Text »
| PDF »
- Lethal Cutaneous Disease in Transgenic Mice Conditionally Expressing Type I Human T Cell Leukemia Virus Tax.
- H. Kwon, L. Ogle, B. Benitez, J. Bohuslav, M. Montano, D. W. Felsher, and W. C. Greene (2005)
J. Biol. Chem.
280, 35713-35722
| Abstract »
| Full Text »
| PDF »
- Ubiquitination of Human T-Cell Leukemia Virus Type 1 Tax Modulates Its Activity.
- J.-M. Peloponese Jr., H. Iha, V. R. K. Yedavalli, A. Miyazato, Y. Li, K. Haller, M. Benkirane, and K.-T. Jeang (2004)
J. Virol.
78, 11686-11695
| Abstract »
| Full Text »
| PDF »
- Estradiol Represses Human T-cell Leukemia Virus Type 1 Tax Activation of Tumor Necrosis Factor-alpha Gene Transcription.
- C. Tzagarakis-Foster, R. Geleziunas, A. Lomri, J. An, and D. C. Leitman (2002)
J. Biol. Chem.
277, 44772-44777
| Abstract »
| Full Text »
| PDF »
- Human T-Lymphotropic Virus Type 1 Oncoprotein Tax Promotes S-Phase Entry but Blocks Mitosis.
- M.-H. Liang, T. Geisbert, Y. Yao, S. H. Hinrichs, and C.-Z. Giam (2002)
J. Virol.
76, 4022-4033
| Abstract »
| Full Text »
| PDF »
- Reciprocal Interactions between Human T-Lymphotropic Virus Type 1 and Prostaglandins: Implications for Viral Transmission.
- M. Moriuchi, H. Inoue, and H. Moriuchi (2001)
J. Virol.
75, 192-198
| Abstract »
| Full Text »
- Discordance between Bovine Leukemia Virus Tax Immortalization In Vitro and Oncogenicity In Vivo.
- J.-C. Twizere, P. Kerkhofs, A. Burny, D. Portetelle, R. Kettmann, and L. Willems (2000)
J. Virol.
74, 9895-9902
| Abstract »
| Full Text »
- Identification of Poly(ADP-Ribose) Polymerase as a Transcriptional Coactivator of the Human T-Cell Leukemia Virus Type 1 Tax Protein.
- M. G. Anderson, K. E. S. Scoggin, C. M. Simbulan-Rosenthal, and J. A. Steadman (2000)
J. Virol.
74, 2169-2177
| Abstract »
| Full Text »
- Induction of Adult T-Cell Leukemia-Like Lymphoproliferative Disease and Its Inhibition by Adoptive Immunotherapy in T-Cell-Deficient Nude Rats Inoculated with Syngeneic Human T-Cell Leukemia Virus Type 1-Immortalized Cells.
- T. Ohashi, S. Hanabuchi, H. Kato, Y. Koya, F. Takemura, K. Hirokawa, T. Yoshiki, Y. Tanaka, M. Fujii, and M. Kannagi (1999)
J. Virol.
73, 6031-6040
| Abstract »
| Full Text »
- CD28-Independent Costimulation of T Cells by OX40 Ligand and CD70 on Activated B Cells.
- H. Akiba, H. Oshima, K. Takeda, M. Atsuta, H. Nakano, A. Nakajima, C. Nohara, H. Yagita, and K. Okumura (1999)
J. Immunol.
162, 7058-7066
| Abstract »
| Full Text »
| PDF »
- Disruption of Nucleotide Excision Repair by the Human T-Cell Leukemia Virus Type 1 Tax Protein.
- S.-Y. Kao and S. J. Marriott (1999)
J. Virol.
73, 4299-4304
| Abstract »
| Full Text »
- Involvement of NF-AT in Type I Human T-cell Leukemia Virus Tax-mediated Fas Ligand Promoter Transactivation.
- I. Rivera, E. W. Harhaj, and S.-C. Sun (1998)
J. Biol. Chem.
273, 22382-22388
| Abstract »
| Full Text »
| PDF »
- Specific interaction of HTLV tax protein and a human type IV neuronal intermediate filament protein.
- T. R. Reddy, X. Li, Y. Jones, M. H. Ellisman, G. Y. Ching, R. K. H. Liem, and F. Wong-Staal (1998)
PNAS
95, 702-707
| Abstract »
| Full Text »
| PDF »
- Identification of an Osteoclast Transcription Factor That Binds to the Human T Cell Leukemia Virus Type I-Long Terminal Repeat Enhancer Element.
- D. Inoue, P. Santiago, W. C. Horne, and R. Baron (1997)
J. Biol. Chem.
272, 25386-25393
| Abstract »
| Full Text »
| PDF »
- Human T-cell Leukemia Virus Type I Tax Protein Transactivates RNA Polymerase III Promoter in Vitro and in Vivo.
- G. Piras, J. Dittmer, M. F. Radonovich, and J. N. Brady (1996)
J. Biol. Chem.
271, 20501-20506
| Abstract »
| Full Text »
| PDF »
- HTLV tax and Mycosis Fungoides.
- B. A. Pancake and D. Zucker-Franklin (1993)
N. Engl. J. Med.
329, 580
| Full Text »
- Ablation of transplanted HTLV-I Tax-transformed tumors in mice by antisense inhibition of NF-kappa B.
- I Kitajima, T Shinohara, J Bilakovics, D. Brown, X Xu, and M Nerenberg (1992)
Science
258, 1792-1795
| Abstract »
| PDF »
- Transgenic models of tumor development.
- J. Adams and S Cory (1991)
Science
254, 1161-1167
| Abstract »
| PDF »
- Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-I.
- Y Iwakura, M Tosu, E Yoshida, M Takiguchi, K Sato, I Kitajima, K Nishioka, K Yamamoto, T Takeda, M Hatanaka, et al. (1991)
Science
253, 1026-1028
| Abstract »
| PDF »
- Progressive encephalopathy and myopathy in transgenic mice expressing human foamy virus genes.
- K Bothe, A Aguzzi, H Lassmann, A Rethwilm, and I Horak (1991)
Science
253, 555-557
| Abstract »
| PDF »
- Identification of HTLV-I tax trans-activator mutants exhibiting novel transcriptional phenotypes..
- M R Smith and W C Greene (1990)
Genes & Dev.
4, 1875-1885
| Abstract »
| PDF »
- Transgenic mice as probes into complex systems.
- D Hanahan (1989)
Science
246, 1265-1275
| Abstract »
| PDF »
- Amplification and molecular cloning of HTLV-I sequences from DNA of multiple sclerosis patients.
- E. Reddy, M Sandberg-Wollheim, R. Mettus, P. Ray, E DeFreitas, and H Koprowski (1989)
Science
243, 529-533
| Abstract »
| PDF »
- Human T cell leukemia viruses use a receptor determined by human chromosome 17.
- M. Sommerfelt, B. Williams, P. Clapham, E Solomon, P. Goodfellow, and R. Weiss (1988)
Science
242, 1557-1559
| Abstract »
| PDF »
- Regulation of HIV and HTLV gene expression..
- H Varmus (1988)
Genes & Dev.
2, 1055-1062
| PDF »
- Transgenic animals.
- R Jaenisch (1988)
Science
240, 1468-1474
| Abstract »
| PDF »
- Molecular genetics: applications to the clinical neurosciences.
- J. Martin (1987)
Science
238, 765-772
| Abstract »
| PDF »
- The tat gene of human T-lymphotropic virus type 1 induces mesenchymal tumors in transgenic mice.
- M Nerenberg, S. Hinrichs, R. Reynolds, G Khoury, and G Jay (1987)
Science
237, 1324-1329
| Abstract »
| PDF »
|
|
